Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Listed
Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 561 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688315 · 1 venue

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司自愿性公告
Regulatory Filings Classification · 82% confidence The document is a voluntary corporate announcement by the board, clarifying the company’s erroneous inclusion in a U.S. Department of Defense list under the 2021 NDAA. It contains no financial statements or managerial changes, nor is it a simple publication notice of another report. It is a compliance/regulatory announcement about legal/regulatory status, which falls under the general Regulatory Filings category (RNS).
2026-06-09 Chinese
北京诺禾致源科技股份有限公司2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 92% confidence The document is an implementation announcement of the company’s 2025 profit distribution (dividend) scheme, detailing per-share cash dividend, record/ex-dividend/payment dates, calculation basis, and tax withholding rules. This clearly matches a Notice of Dividend Amount filing.
2026-06-02 Chinese
中信证券股份有限公司关于北京诺禾致源科技股份有限公司差异化分红事项的核查意见
Regulatory Filings Classification · 88% confidence The document is a sponsor’s investigation opinion (“核查意见”) by the sponsoring institution (CITIC Securities) on the company’s differential dividend arrangement and compliance with listing rules. It does not itself constitute the official dividend notice to shareholders nor provide full financial statements; rather it is a compliance letter under exchange rules. Therefore it falls under general regulatory/compliance filings as a fallback category.
2026-06-02 Chinese
北京诺禾致源科技股份有限公司2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "2025 Annual General Meeting Resolution Announcement" for Beijing Nuohe Zhiyuan Technology Co., Ltd. It details the date and location of the AGM, attendance, voting results on various proposals including the 2025 annual board work report, independent director report, 2025 annual report and summary, profit distribution plan, stock issuance authorization, borrowing plan, audit firm appointment, governance system revisions, and director remuneration. The document includes detailed voting statistics and legal compliance statements. It is clearly an announcement of the resolutions passed at the Annual General Meeting, including voting results and procedural confirmations. The document length is 4490 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2026-05-08 Chinese
北京市中伦律师事务所关于北京诺禾致源科技股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm (Zhong Lun) regarding the legality of the 2025 Annual General Meeting (AGM) of Beijing Nuohe Zhiyuan Technology Co., Ltd. It details the procedures of convening, holding, attendance, voting, and results of the AGM. The document does not contain the actual annual report or financial statements but rather certifies the legality and compliance of the AGM process and voting results. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports the official voting outcomes and confirms the legitimacy of the shareholder meeting proceedings. The document length (5599 characters) and content confirm it is not a brief announcement nor a full annual report but a legal opinion on the AGM and its voting results.
2026-05-08 Chinese
北京诺禾致源科技股份有限公司2025年度非经营性资金占用及其他关联资金往来情况专项报告
Audit Report / Information Classification · 94% confidence The document is a standalone specialized audit report (“专项报告”) issued by a certified public accounting firm (BDO/立信) concerning non-operating funds occupancy and related party transactions for Beijing Novogene Science and Technology Co., Ltd. It contains audit procedures, report numbers, auditor signatures, and detailed schedules, and is not the full annual report or just an announcement. This fits the definition of an Audit Report / Information. Therefore, it should be classified as AR. FY 2025
2026-04-14 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.